Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China · Delayed Price · Currency is CNY 24.24
-1.28 (-5.02%)
Aug 21, 2026, 3:00 PM CST
Nanjing Vazyme Biotech Market Cap
Nanjing Vazyme Biotech has a market cap or net worth of 12.53 billion as of August 21, 2026. Its market cap has increased by 23.61% in one year.
Market Cap
12.53B
Enterprise Value
10.59B
Revenue
1.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
24.24
ChartMarket Cap Chart
Since November 15, 2021, Nanjing Vazyme Biotech's market cap has decreased from 34.14B to 12.53B, a decrease of -63.29%. That is a compound annual growth rate of -18.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 12.53B | 57.38% |
| Dec 31, 2025 | 7.96B | -9.63% |
| Dec 31, 2024 | 8.81B | -31.21% |
| Dec 29, 2023 | 12.81B | -39.74% |
| Dec 30, 2022 | 21.26B | -49.87% |
| Dec 31, 2021 | 42.40B | 24.19% |
| Nov 15, 2021 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InventisBio | 12.47B |
| Tibet Cheezheng Tibetan Medicine | 11.53B |
| Chengdu Olymvax Biopharmaceuticals | 11.08B |
| Staidson (Beijing) BioPharmaceuticals | 10.95B |
| Chengzhi | 10.87B |
| Inner Mongolia Furui Medical Science | 10.84B |
| Hualan Biological Vaccine | 10.41B |
| Pacific Shuanglin Bio-pharmacy | 10.15B |